Does EVEROLIMUS Cause Hypercholesterolaemia? 123 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 123 reports of Hypercholesterolaemia have been filed in association with EVEROLIMUS (EVEROLIMUS). This represents 0.3% of all adverse event reports for EVEROLIMUS.
123
Reports of Hypercholesterolaemia with EVEROLIMUS
0.3%
of all EVEROLIMUS reports
12
Deaths
54
Hospitalizations
How Dangerous Is Hypercholesterolaemia From EVEROLIMUS?
Of the 123 reports, 12 (9.8%) resulted in death, 54 (43.9%) required hospitalization, and 15 (12.2%) were considered life-threatening.
Is Hypercholesterolaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVEROLIMUS. However, 123 reports have been filed with the FAERS database.
What Other Side Effects Does EVEROLIMUS Cause?
Death (5,090)
Malignant neoplasm progression (3,789)
Diarrhoea (3,061)
Fatigue (2,946)
Stomatitis (2,692)
Nausea (2,079)
Dyspnoea (1,925)
Drug ineffective (1,837)
Pyrexia (1,664)
Decreased appetite (1,633)
What Other Drugs Cause Hypercholesterolaemia?
ALENDRONATE (1,607)
METHOTREXATE (1,547)
TOCILIZUMAB (1,483)
ADALIMUMAB (1,479)
ABATACEPT (1,410)
RITUXIMAB (1,389)
PREDNISONE (1,377)
INFLIXIMAB (1,338)
DICLOFENAC (1,331)
LEFLUNOMIDE (1,322)
Which EVEROLIMUS Alternatives Have Lower Hypercholesterolaemia Risk?
EVEROLIMUS vs EVOLOCUMAB
EVEROLIMUS vs EXELON
EVEROLIMUS vs EXEMESTANE
EVEROLIMUS vs EXENATIDE
EVEROLIMUS vs EXFORGE